MedTrace Logo

Leaders Free III: BioFreedom™ Clinical Trial

NCT03118895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 404

Last updated 2024-02-29

No results posted yet for this study

Summary

A study evaluating the safety and efficacy of the BioFreedom™ Biolimus A9™ coated Cobalt Chromium coronary stent system in patients at high risk of bleeding

Conditions

Interventions

DEVICE

BioFreedom™ BA9™ drug-coated stent

Drug-coated stent for coronary arteries

Sponsors & Collaborators

  • European Cardiovascular Research Center

    collaborator NETWORK

  • Biosensors Europe SA

    lead INDUSTRY

Principal Investigators

  • Franz Eberli, Prof. · Chief of Cardiology - Triemli Hospital Zurich - Switzerland

  • Philippe Garot, MD · Hôpital Privé Claude Galien ICPS - France

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2019-09-05
Completion
2022-11-18

Countries

  • France
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03118895 on ClinicalTrials.gov